Similar but Distinct Comorbidity Patterns Between Polycystic Ovary Syndrome and Endometriosis in Korean Women: A Nationwide Cohort Study
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Polycystic ovary syndrome (PCOS) and endometriosis have distinct co-occurring conditions. PCOS links to metabolic and pregnancy issues, while endometriosis is tied to reproductive organ neoplasms and pain. Both share infertility and glaucoma risks.
Area Of Science
- Reproductive endocrinology and women's health research.
- Epidemiological analysis of gynecological disorders.
Background
- Polycystic ovary syndrome (PCOS) and endometriosis are significant risk factors for female reproductive health.
- Underlying mechanisms affecting fertility may differ, leading to varied outcomes.
- Understanding co-morbidity patterns is crucial for targeted interventions.
Purpose Of The Study
- To examine and contrast disease co-occurrence patterns in PCOS and endometriosis.
- To analyze comorbidities in Asian women of reproductive age using nationwide insurance data.
Main Methods
- Analysis of health insurance and examination data from 157,662 Korean women (aged 15-45).
- Mapping of ICD-10 codes to phecodes for comprehensive analysis.
- Multivariate logistic regression to assess comorbidity patterns against control groups.
Main Results
- PCOS associated with metabolic disorders (hyperlipidemia, type 2 diabetes), GI issues, and pregnancy complications.
- Endometriosis linked to benign neoplasms of reproductive/digestive organs, endometrial hyperplasia, and angina pectoris.
- Infertility and glaucoma significantly associated with both PCOS and endometriosis; PCOS shows broader symptom spectrum than endometriosis's pain predominance.
Conclusions
- PCOS and endometriosis, though affecting similar demographics, rarely co-occur and present unique comorbidity profiles.
- Distinct healthcare strategies tailored to these profiles can improve long-term patient outcomes.
- Further research needed to elucidate underlying mechanisms and contrasting comorbidity patterns.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...